created image of Biotech 2020 outlook

Biotech Bonanza: 2020 Outlook In An Election Year

Biotechs closed out 2019 on a strong note with the fourth quarter providing the longest sustained rally of the entire year.  Favorable regulatory shifting, a timely ramp-up in M&A, FDA approvals,

The Thundering Quant Bulls

APRIL 21, 2016 Yesterday, April 20, the S&P500 reached a critical stock market technical level of 2100. This is the level around which the index had peaked in November 2015. Why is this

Our Investing Biases Cost Us Investment Returns!

APRIL 07, 2016 We are influenced by the pool of emotions and experiences accumulated over our lifetime, which create certain preferences or proclivities in our thinking. We lean on these tendencies, when making